Read news on Trial with our app.
Read more in the app
Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders
Novel dual-target IL-17A/F monoclonal antibody XKH004 shows 52-week efficacy and safety in active ankylosing spondylitis in phase 3 trial
Peppermint Oil Lowered Blood Pressure by 8 Points in Just 20 Days, Trial Finds
Support groups for parents halved violence against children in wartime Ukraine, trial finds
First-in-human pilot trial for new sickle cell disease gene therapy approach proves quicker, more efficient than industry average
Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
Trial shows chilled platelets could safely expand lifesaving supply to bleeding patients - EurekAlert!
Trial shows chilled platelets could safely expand lifesaving supply to bleeding patients
Inside the trial for a vaccine to end malaria
Trial focuses on duration of therapeutic hypothermia for out-of-hospital cardiac arrests - EurekAlert!
First trial confirms swimming reduces disability from chronic back pain - EurekAlert!
Gum Disease Improved With Just 6 Weeks of Taking Bacteria-Loaded Gummies
Non-Invasive Brain Stimulation 'Significantly' Improves Depression in Just 10 Days, Trial Finds
UCSF screens first patients in novel Alzheimer's trial - EurekAlert!
Nordic walking significantly reduces depression symptoms in as little as five weeks, trial finds
World first: First phase 3 trial of in vivo CRISPR therapy successfully completed CRISPR treatment comes one step closer to reality - EurekAlert!
Remote monitoring alone fails to reduce readmissions for sepsis, trial finds - EurekAlert!
